These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21681499)

  • 1. Retrospective study on the effect of tight glucose control in postoperative sepsis patients using an artificial pancreas.
    Takahashi G; Matsumoto N; Shozushima T; Onodera C; Kan S; Akitomi S; Hoshikawa K; Kikkawa T; Kojika M; Inoue Y; Suzuki K; Wakabayashi G; Endo S
    J Infect Chemother; 2011 Dec; 17(6):812-20. PubMed ID: 21681499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study on glucose control with an artificial pancreas in postoperative sepsis patients.
    Takahashi G; Sato N; Matsumoto N; Shozushima T; Hoshikawa K; Akitomi S; Kikkawa T; Onodera C; Kojika M; Inoue Y; Suzuki K; Wakabayashi G; Endo S
    Eur Surg Res; 2011; 47(1):32-8. PubMed ID: 21576972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.
    Mita N; Kawahito S; Soga T; Takaishi K; Kitahata H; Matsuhisa M; Shimada M; Kinoshita H; Tsutsumi YM; Tanaka K
    J Artif Organs; 2017 Mar; 20(1):76-83. PubMed ID: 27557726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
    Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
    Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease.
    Yatabe T; Nakamura R; Kitagawa H; Munekage M; Hanazaki K
    J Artif Organs; 2016 Mar; 19(1):100-3. PubMed ID: 26194122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of bedside artificial pancreas for postoperative glycemic control in cardiac surgery.
    Shin U; Naoko H; Michinori T; Yuya K; Yuka S; Yuki N; Motoharu K; Soichiro H; Mitsuo K; Yu Y; Tokito K; Satoru K; Kazuki D; Tetsuya O; Hirohisa M; Nobuhiko M; Takeshi O
    J Artif Organs; 2021 Jun; 24(2):225-233. PubMed ID: 33155103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative tight glycemic control using artificial pancreas decreases infectious complications via suppression of inflammatory cytokines in patients who underwent pancreaticoduodenectomy: A prospective, non-randomized clinical trial.
    Akabori H; Tani M; Kitamura N; Maehira H; Imashuku Y; Tsujita Y; Shimizu T; Kitagawa H; Eguchi Y
    Am J Surg; 2020 Aug; 220(2):365-371. PubMed ID: 31836178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy: tight glycemic control may be justified in order to avoid brittle diabetes.
    Hanazaki K; Yatabe T; Kobayashi M; Tsukamoto Y; Kinoshita Y; Munekage M; Kitagawa H
    Biomed Mater Eng; 2013; 23(1-2):109-16. PubMed ID: 23442241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose control using a closed-loop device decreases inflammation after cardiovascular surgery without increasing hypoglycemia risk.
    Tamura T; Yatabe T; Namikawa T; Hanazaki K; Yokoyama M
    J Artif Organs; 2019 Jun; 22(2):154-159. PubMed ID: 30456660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An insulin infusion protocol in critically ill cardiothoracic surgery patients.
    Zimmerman CR; Mlynarek ME; Jordan JA; Rajda CA; Horst HM
    Ann Pharmacother; 2004; 38(7-8):1123-9. PubMed ID: 15150382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an artificial pancreas device for achieving tight perioperative glycemic control in living donor liver transplantation.
    Soyama A; Kugiyama T; Hara T; Hidaka M; Hamada T; Okada S; Adachi T; Ono S; Takatsuki M; Eguchi S
    Artif Organs; 2019 Mar; 43(3):270-277. PubMed ID: 30332505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Tight Glucose Control Reduces Postoperative Adverse Events in Nondiabetic Cardiac Surgery Patients.
    Bláha J; Mráz M; Kopecký P; Stříteský M; Lipš M; Matias M; Kunstýř J; Pořízka M; Kotulák T; Kolníková I; Šimanovská B; Zakharchenko M; Rulíšek J; Šachl R; Anýž J; Novák D; Lindner J; Hovorka R; Svačina Š; Haluzík M
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3081-9. PubMed ID: 26079777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis.
    Wang YY; Hu SF; Ying HM; Chen L; Li HL; Tian F; Zhou ZF
    BMC Endocr Disord; 2018 Jun; 18(1):42. PubMed ID: 29929558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Site Infections and Inflammatory Reaction After Cardiac Surgery; Bedside Artificial Pancreas Versus Conventional Insulin Therapy: A Propensity Score-Matched Analysis.
    Fujii T; Hirai T; Suzuki S; Nishiwaki K
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):840-846. PubMed ID: 34103216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection.
    Hanazaki K
    World J Gastroenterol; 2012 Aug; 18(29):3787-9. PubMed ID: 22876028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with intraoperative use of artificial pancreas during local resection of insulinoma.
    Asano Y; Kato H; Arakawa S; Ito M; Shimura M; Koike D; Hayashi C; Kawai T; Higashiguchi T; Horiguchi A
    Clin J Gastroenterol; 2022 Oct; 15(5):1012-1017. PubMed ID: 35969322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients.
    Schultz MJ; Harmsen RE; Korevaar JC; Abu-Hanna A; Van Braam Houckgeest F; Van Der Sluijs JP; Spronk PE
    Minerva Anestesiol; 2012 Sep; 78(9):982-95. PubMed ID: 22531562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An artificial pancreas provided a novel model of blood glucose level variability in beagles.
    Munekage M; Yatabe T; Kitagawa H; Takezaki Y; Tamura T; Namikawa T; Hanazaki K
    J Artif Organs; 2015 Dec; 18(4):387-90. PubMed ID: 26253251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel artificial pancreas: closed loop glycemic control system with continuous blood glucose monitoring.
    Tsukamoto Y; Kinoshita Y; Kitagawa H; Munekage M; Munekage E; Takezaki Y; Yatabe T; Yamashita K; Yamazaki R; Okabayashi T; Tarumi M; Kobayashi M; Mishina S; Hanazaki K
    Artif Organs; 2013 Apr; 37(4):E67-73. PubMed ID: 23506242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia.
    Hanazaki K; Kitagawa H; Yatabe T; Munekage M; Dabanaka K; Takezaki Y; Tsukamoto Y; Asano T; Kinoshita Y; Namikawa T
    Am J Surg; 2014 Jun; 207(6):935-41. PubMed ID: 24480234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.